Tsai YC - Search Results

1

Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer.

Fan YC, Fong YC, Kuo CT, Li CW, Chen WY, Lin JD, Bürtin F, Linnebacher M, Bui QT, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Cell Biosci. 2023 Aug 10;13(1):147. doi: 10.1186/s13578-023-01090-8. Cell Biosci. 2023. PMID: 37563620 Free PMC article.

2

Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.

Tsai YC, Chen WY, Siu MK, Tsai HY, Yin JJ, Huang J, Liu YN. Tsai YC, et al. Among authors: tsai hy. Cancer Lett. 2017 Jan 1;384:1-8. doi: 10.1016/j.canlet.2016.10.014. Epub 2016 Oct 13. Cancer Lett. 2017. PMID: 27746161

3

Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.

Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN, Huang J, Liu YN. Chen WY, et al. Among authors: tsai yc. Sci Signal. 2017 Aug 15;10(492):eaam6826. doi: 10.1126/scisignal.aam6826. Sci Signal. 2017. PMID: 28811384

4

Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.

Chen MC, Tsai YC, Tseng JH, Liou JJ, Horng S, Wen HC, Fan YC, Zhong WB, Hsu SP. Chen MC, et al. Among authors: tsai yc. Int J Mol Sci. 2017 Dec 13;18(12):2690. doi: 10.3390/ijms18122690. Int J Mol Sci. 2017. PMID: 29236027 Free PMC article.

5

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.

Tsai YC, Zeng T, Abou-Kheir W, Yeh HL, Yin JJ, Lee YC, Chen WY, Liu YN. Tsai YC, et al. Mol Cancer. 2018 Feb 19;17(1):42. doi: 10.1186/s12943-018-0785-1. Mol Cancer. 2018. PMID: 29455655 Free PMC article.

6

Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2.

Tsai YC, Chen WY, Abou-Kheir W, Zeng T, Yin JJ, Bahmad H, Lee YC, Liu YN. Tsai YC, et al. Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1717-1727. doi: 10.1016/j.bbadis.2018.02.016. Epub 2018 Mar 21. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29477409 Free article.

7

A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.

Zhong WB, Tsai YC, Chin LH, Tseng JH, Tang LW, Horng S, Fan YC, Hsu SP. Zhong WB, et al. Among authors: tsai yc. Int J Mol Sci. 2018 Jun 22;19(7):1834. doi: 10.3390/ijms19071834. Int J Mol Sci. 2018. PMID: 29932104 Free PMC article.

8

Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model.

Fan YC, Chen WY, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Biology (Basel). 2020 Mar 31;9(4):67. doi: 10.3390/biology9040067. Biology (Basel). 2020. PMID: 32244522 Free PMC article.

9

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression.

Fan YC, Lee KD, Tsai YC. Fan YC, et al. Among authors: tsai yc. Biomedicines. 2020 Dec 13;8(12):602. doi: 10.3390/biomedicines8120602. Biomedicines. 2020. PMID: 33322099 Free PMC article.

10

Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.

Tsai YC, Huang CY, Hsueh YM, Fan YC, Fong YC, Huang SP, Geng JH, Chen LC, Lu TL, Bao BY. Tsai YC, et al. Life Sci. 2021 Jun 15;275:119396. doi: 10.1016/j.lfs.2021.119396. Epub 2021 Mar 24. Life Sci. 2021. PMID: 33774030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,607 results

Search Page

Filters